Prof Adam Waldman

MRC Institute of Genetics & Molecular Medicine CANCER RESEARCH UK Imaging

The overall theme of my research is development and validation of quantitative and molecular imaging biomarkers which reflect key features of genetics and metabolism in human glioma, for clinical stratification, therapeutic planning and drug development:

Experimental phase MRI and PET imaging studies of intermediary metabolism, validated against tissue metabolic markers from defined tumour regions; for more reliable tumour characterisation, and identification of potential therapeutic targets.

Translational multi-centre platform studies of early therapeutic response in GBM using quantitative diffusion imaging for improved endpoints in clinical trials and clinical decision-making.

Quantitative MRI for treatment stratification and planning in adult supratentorial low grade glioma.

Development of PET-MRI methodology and co-analysis for improved glioma characterization.

Integration of quantitative MRI and PET into surgical neuro-navigation systems, for improved targeting for biopsy and surgical resection.

dont miss

Biomarkers in Adult Glioma

EVEN MORE SEMINARS

  • Sanjay Prabhu, MBBS: Speaking at the European Neurological Convention

    Sanjay Prabhu, MBBS
    Harvard Medical School / Boston Children’s Hospital

    Evolving role of machine learning in brain tumour imaging

  • Andy Rogers: Speaking at the European Neurological Convention

    Andy Rogers
    Nottingham University Hospitals

    Interventional staff dose reduction: Gaining insight through new technology

  • Dr Jagrit Shah: Speaking at the European Neurological Convention

    Dr Jagrit Shah
    Vice President of the British Society of Head & Neck Imaging

    Chairing Session 3. Upper Aerodigestive Tract

  • Dr Nick Perry: Speaking at the European Neurological Convention

    Dr Nick Perry
    DenseBreast-info.org / London Breast Institute

    Dense Breasts – an issue for the UK?

  • Prof Adam Waldman: Speaking at the European Neurological Convention

    Prof Adam Waldman
    MRC Institute of Genetics & Molecular Medicine CANCER RESEARCH UK Imaging

    Biomarkers in Adult Glioma